Is vasomotion in cerebral arteries impaired in Alzheimer's disease?

Luigi Yuri Di Marco, Eszter Farkas, Chris Martin, Annalena Venneri, Alejandro F. Frangi

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

A substantial body of evidence supports the hypothesis of a vascular component in the pathogenesis of Alzheimer's disease (AD). Cerebral hypoperfusion and blood-brain barrier dysfunction have been indicated as key elements of this pathway. Cerebral amyloid angiopathy (CAA) is a cerebrovascular disorder, frequent in AD, characterized by the accumulation of amyloid-′ (A′) peptide in cerebral blood vessel walls. CAA is associated with loss of vascular integrity, resulting in impaired regulation of cerebral circulation, and increased susceptibility to cerebral ischemia, microhemorrhages, and white matter damage. Vasomotion-the spontaneous rhythmic modulation of arterial diameter, typically observed in arteries/arterioles in various vascular beds including the brain-is thought to participate in tissue perfusion and oxygen delivery regulation. Vasomotion is impaired in adverse conditions such as hypoperfusion and hypoxia. The perivascular and glymphatic pathways of A′ clearance are thought to be driven by the systolic pulse. Vasomotion produces diameter changes of comparable amplitude, however at lower rates, and could contribute to these mechanisms of A′ clearance. In spite of potential clinical interest, studies addressing cerebral vasomotion in the context of AD/CAA are limited. This study reviews the current literature on vasomotion, and hypothesizes potential paths implicating impaired cerebral vasomotion in AD/CAA. A′ and oxidative stress cause vascular tone dysregulation through direct effects on vascular cells, and indirect effects mediated by impaired neurovascular coupling.Vascular tone dysregulation is further aggravated by cholinergic deficit and results in depressed cerebrovascular reactivity and (possibly) impaired vasomotion, aggravating regional hypoperfusion and promoting further A′ and oxidative stress accumulation.

Original languageEnglish
Pages (from-to)35-53
Number of pages19
JournalJournal of Alzheimer's Disease
Volume46
Issue number1
DOIs
Publication statusPublished - May 7 2015

Fingerprint

Cerebral Arteries
Blood Vessels
Alzheimer Disease
Cerebral Amyloid Angiopathy
Cerebrovascular Circulation
Oxidative Stress
Cerebrovascular Disorders
Arterioles
Brain Ischemia
Blood-Brain Barrier
Amyloid
Cholinergic Agents
Pulse
Arteries
Perfusion
Oxygen
Peptides
Brain

Keywords

  • Alzheimer's disease
  • cerebral amyloid angiopathy
  • cerebral autoregulation
  • endothelium
  • perivascular drainage
  • vascular smooth muscle cell
  • vasomotion

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Di Marco, L. Y., Farkas, E., Martin, C., Venneri, A., & Frangi, A. F. (2015). Is vasomotion in cerebral arteries impaired in Alzheimer's disease? Journal of Alzheimer's Disease, 46(1), 35-53. https://doi.org/10.3233/JAD-142976

Is vasomotion in cerebral arteries impaired in Alzheimer's disease? / Di Marco, Luigi Yuri; Farkas, Eszter; Martin, Chris; Venneri, Annalena; Frangi, Alejandro F.

In: Journal of Alzheimer's Disease, Vol. 46, No. 1, 07.05.2015, p. 35-53.

Research output: Contribution to journalArticle

Di Marco, LY, Farkas, E, Martin, C, Venneri, A & Frangi, AF 2015, 'Is vasomotion in cerebral arteries impaired in Alzheimer's disease?', Journal of Alzheimer's Disease, vol. 46, no. 1, pp. 35-53. https://doi.org/10.3233/JAD-142976
Di Marco, Luigi Yuri ; Farkas, Eszter ; Martin, Chris ; Venneri, Annalena ; Frangi, Alejandro F. / Is vasomotion in cerebral arteries impaired in Alzheimer's disease?. In: Journal of Alzheimer's Disease. 2015 ; Vol. 46, No. 1. pp. 35-53.
@article{04938e95ea904cc1bb1d70c33c21980f,
title = "Is vasomotion in cerebral arteries impaired in Alzheimer's disease?",
abstract = "A substantial body of evidence supports the hypothesis of a vascular component in the pathogenesis of Alzheimer's disease (AD). Cerebral hypoperfusion and blood-brain barrier dysfunction have been indicated as key elements of this pathway. Cerebral amyloid angiopathy (CAA) is a cerebrovascular disorder, frequent in AD, characterized by the accumulation of amyloid-′ (A′) peptide in cerebral blood vessel walls. CAA is associated with loss of vascular integrity, resulting in impaired regulation of cerebral circulation, and increased susceptibility to cerebral ischemia, microhemorrhages, and white matter damage. Vasomotion-the spontaneous rhythmic modulation of arterial diameter, typically observed in arteries/arterioles in various vascular beds including the brain-is thought to participate in tissue perfusion and oxygen delivery regulation. Vasomotion is impaired in adverse conditions such as hypoperfusion and hypoxia. The perivascular and glymphatic pathways of A′ clearance are thought to be driven by the systolic pulse. Vasomotion produces diameter changes of comparable amplitude, however at lower rates, and could contribute to these mechanisms of A′ clearance. In spite of potential clinical interest, studies addressing cerebral vasomotion in the context of AD/CAA are limited. This study reviews the current literature on vasomotion, and hypothesizes potential paths implicating impaired cerebral vasomotion in AD/CAA. A′ and oxidative stress cause vascular tone dysregulation through direct effects on vascular cells, and indirect effects mediated by impaired neurovascular coupling.Vascular tone dysregulation is further aggravated by cholinergic deficit and results in depressed cerebrovascular reactivity and (possibly) impaired vasomotion, aggravating regional hypoperfusion and promoting further A′ and oxidative stress accumulation.",
keywords = "Alzheimer's disease, cerebral amyloid angiopathy, cerebral autoregulation, endothelium, perivascular drainage, vascular smooth muscle cell, vasomotion",
author = "{Di Marco}, {Luigi Yuri} and Eszter Farkas and Chris Martin and Annalena Venneri and Frangi, {Alejandro F.}",
year = "2015",
month = "5",
day = "7",
doi = "10.3233/JAD-142976",
language = "English",
volume = "46",
pages = "35--53",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Is vasomotion in cerebral arteries impaired in Alzheimer's disease?

AU - Di Marco, Luigi Yuri

AU - Farkas, Eszter

AU - Martin, Chris

AU - Venneri, Annalena

AU - Frangi, Alejandro F.

PY - 2015/5/7

Y1 - 2015/5/7

N2 - A substantial body of evidence supports the hypothesis of a vascular component in the pathogenesis of Alzheimer's disease (AD). Cerebral hypoperfusion and blood-brain barrier dysfunction have been indicated as key elements of this pathway. Cerebral amyloid angiopathy (CAA) is a cerebrovascular disorder, frequent in AD, characterized by the accumulation of amyloid-′ (A′) peptide in cerebral blood vessel walls. CAA is associated with loss of vascular integrity, resulting in impaired regulation of cerebral circulation, and increased susceptibility to cerebral ischemia, microhemorrhages, and white matter damage. Vasomotion-the spontaneous rhythmic modulation of arterial diameter, typically observed in arteries/arterioles in various vascular beds including the brain-is thought to participate in tissue perfusion and oxygen delivery regulation. Vasomotion is impaired in adverse conditions such as hypoperfusion and hypoxia. The perivascular and glymphatic pathways of A′ clearance are thought to be driven by the systolic pulse. Vasomotion produces diameter changes of comparable amplitude, however at lower rates, and could contribute to these mechanisms of A′ clearance. In spite of potential clinical interest, studies addressing cerebral vasomotion in the context of AD/CAA are limited. This study reviews the current literature on vasomotion, and hypothesizes potential paths implicating impaired cerebral vasomotion in AD/CAA. A′ and oxidative stress cause vascular tone dysregulation through direct effects on vascular cells, and indirect effects mediated by impaired neurovascular coupling.Vascular tone dysregulation is further aggravated by cholinergic deficit and results in depressed cerebrovascular reactivity and (possibly) impaired vasomotion, aggravating regional hypoperfusion and promoting further A′ and oxidative stress accumulation.

AB - A substantial body of evidence supports the hypothesis of a vascular component in the pathogenesis of Alzheimer's disease (AD). Cerebral hypoperfusion and blood-brain barrier dysfunction have been indicated as key elements of this pathway. Cerebral amyloid angiopathy (CAA) is a cerebrovascular disorder, frequent in AD, characterized by the accumulation of amyloid-′ (A′) peptide in cerebral blood vessel walls. CAA is associated with loss of vascular integrity, resulting in impaired regulation of cerebral circulation, and increased susceptibility to cerebral ischemia, microhemorrhages, and white matter damage. Vasomotion-the spontaneous rhythmic modulation of arterial diameter, typically observed in arteries/arterioles in various vascular beds including the brain-is thought to participate in tissue perfusion and oxygen delivery regulation. Vasomotion is impaired in adverse conditions such as hypoperfusion and hypoxia. The perivascular and glymphatic pathways of A′ clearance are thought to be driven by the systolic pulse. Vasomotion produces diameter changes of comparable amplitude, however at lower rates, and could contribute to these mechanisms of A′ clearance. In spite of potential clinical interest, studies addressing cerebral vasomotion in the context of AD/CAA are limited. This study reviews the current literature on vasomotion, and hypothesizes potential paths implicating impaired cerebral vasomotion in AD/CAA. A′ and oxidative stress cause vascular tone dysregulation through direct effects on vascular cells, and indirect effects mediated by impaired neurovascular coupling.Vascular tone dysregulation is further aggravated by cholinergic deficit and results in depressed cerebrovascular reactivity and (possibly) impaired vasomotion, aggravating regional hypoperfusion and promoting further A′ and oxidative stress accumulation.

KW - Alzheimer's disease

KW - cerebral amyloid angiopathy

KW - cerebral autoregulation

KW - endothelium

KW - perivascular drainage

KW - vascular smooth muscle cell

KW - vasomotion

UR - http://www.scopus.com/inward/record.url?scp=84929379204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929379204&partnerID=8YFLogxK

U2 - 10.3233/JAD-142976

DO - 10.3233/JAD-142976

M3 - Article

AN - SCOPUS:84929379204

VL - 46

SP - 35

EP - 53

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 1

ER -